inkjet-bioAM

The project inkjet-bioAM aims to establish the inkjet printing technology into the value chain for manufacturing of medical and pharmaceutical products to improve health care. The project is co-funded by the European Union via the Interregional Innovation Investments (I3) programme. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovati on Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.